MiMedx Group Inc
NASDAQ:MDXG
MiMedx Group Inc
NASDAQ:MDXG
Price:
7.15 USD
0.42%
Market Closed
Updated:
Jun 1, 2024
MiMedx Group Inc
Accrued Liabilities
|
MiMedx Group Inc
Accrued Liabilities Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
MiMedx Group Inc
NASDAQ:MDXG
|
Accrued Liabilities
$27.1m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
15%
|
|
|
Abbvie Inc
NYSE:ABBV
|
Accrued Liabilities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Accrued Liabilities
$5.4B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
8%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Accrued Liabilities
$14.1B
|
CAGR 3-Years
13%
|
CAGR 5-Years
12%
|
CAGR 10-Years
12%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Accrued Liabilities
$2.8B
|
CAGR 3-Years
22%
|
CAGR 5-Years
39%
|
CAGR 10-Years
28%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Accrued Liabilities
$2.4B
|
CAGR 3-Years
17%
|
CAGR 5-Years
26%
|
CAGR 10-Years
28%
|
See Also
What is MiMedx Group Inc's Accrued Liabilities?
Accrued Liabilities
27.1m
USD
27.1m
USD
Based on the financial report for Mar 31, 2024, MiMedx Group Inc's Accrued Liabilities amounts to 27.1m USD.
What is MiMedx Group Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 10Y
15%
15%
Over the last year, the Accrued Liabilities growth was -13%. The average annual Accrued Liabilities growth rates for MiMedx Group Inc have been -17% over the past three years , -12% over the past five years , and 15% over the past ten years .
You don't have any saved screeners yet
